Last reviewed · How we verify

NCT04108442

Patient Satisfaction With Virtual Postoperative Visit

Completed NA Last updated 9 October 2020
What this trial tests

NA trial testing Traditional in Post-Op Complication in 122 participants. Completed in 1 March 2020.

Timeline
1 August 2019
Primary endpoint
1 March 2020
1 March 2020

Quick facts

Lead sponsorNYU Langone Health
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment122
Start date1 August 2019
Primary completion1 March 2020
Estimated completion1 March 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 18 to 60, any sex, with Post-Op Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective, randomized study designed to evaluate the effects of different initial postoperative follow-up modalities. Given the nature of the study, it is not possible for either the surgeons or the subjects to be blinded. To reduce bias that may occur due to each surgeon's personal preference for postoperative follow-up modality, the surgeons (rather than individual subjects) will be randomized to one of two postoperative follow-up modality groups (traditional or virtual).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Traditional

Trials testing the same drug.

Other recruiting trials for Post-Op Complication

Currently open trials in the same condition.

Other NYU Langone Health trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04108442.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing